Common use of Grant Agreement Clause in Contracts

Grant Agreement. BGX hereby excludes from its obligation to grant Access Rights to Bacground including, but not limited to, the following: a) All Background developed by researchers working at BGX who are not participating in the THERACAT project and b) All Background developed by researchers working at BGX and participating in the THERACAT project, where this Background falls outside the scope of the Work Tasks allocated to BGX under the project, and c) All Background developed by researchers working at BGX which is subject to thir party rights or for which BGX needs to obtain permission grant Access Rights. This represents the status at the time of signature of this Consortium Agreement. Attachment 2: Accession document ACCESSION of a new Party to [Acronym of the Project] Consortium Agreement, version […, YYYY-MM-DD] [OFFICIAL NAME OF THE NEW PARTY AS IDENTIFIED IN THE Grant Agreement] hereby consents to become a Party to the Consortium Agreement identified above and accepts all the rights and obligations of a Party starting [date]. [OFFICIAL NAME OF THE COORDINATOR AS IDENTIFIED IN THE Grant Agreement] hereby certifies that the consortium has accepted in the meeting held on [date] the accession of [the name of the new Party] to the consortium starting [date]. This Accession document has been done in 2 originals to be duly signed by the undersigned authorised representatives. [Date and Place] [INSERT NAME OF THE NEW PARTY] Signature(s) Name(s) Title(s) [Date and Place] [INSERT NAME OF THE COORDINATOR] Signature(s) Name(s) Title(s) Attachment 3: List of Third Parties for simplified transfer according to Section 8.3.2. TAU may assign its Results to Ramot at Tel Aviv University Ltd., the commercial arm of TAU, and/or to the researchers of TAU participating in the Project

Grant Agreement. BGX hereby excludes from its obligation to grant Access Rights to Bacground including, but not limited to, the following: a) All Background developed by researchers working at BGX who are not participating in the THERACAT project and b) All Background developed by researchers working at BGX and participating in the THERACAT project, where this Background falls outside the scope of the Work Tasks allocated to BGX under the project, and c) All Background developed by researchers working at BGX which is subject to thir party rights or for which BGX needs to obtain permission grant Access Rights. This represents the status at the time of signature of this Consortium Agreement. Agreement Attachment 2: Accession document document‌ ACCESSION of a new Party to [Acronym of the Project] ELASTIC Consortium Agreement, version […, YYYY-MM-DD] [OFFICIAL NAME OF THE NEW PARTY AS IDENTIFIED IN THE Grant Agreement] hereby consents to become a Party to the Consortium Agreement identified above and accepts all the rights and obligations of a Party starting [date]. [OFFICIAL NAME OF THE COORDINATOR AS IDENTIFIED IN THE Grant Agreement] hereby certifies that the consortium has accepted in the meeting held on [date] the accession of [the name of the new Party] to the consortium starting [date]. This Accession document has been done in 2 originals to be duly signed by the undersigned authorised representatives. [Date and Place] [INSERT NAME OF THE NEW PARTY] Signature(s) Name(s) Title(s) [Date and Place] [INSERT NAME OF THE COORDINATOR] Signature(s) Name(s) Title(s) Attachment 3: List of Third Parties for simplified transfer according to Section 8.3.28.3.2.‌ Information Catalyst SL: Information Catalyst SL (ICE Spain) Attachment 4: Identified Affiliated Entities‌ Thales TRT: THALES GLOBAL SERVICES SAS, THALES SIX GTS SAS, THALES AVS FRANCE, THALES DMS FRANCE SAS, THALES LAS FRANCE, THALES ALENIA SPACE FRANCE, THALES ALENIA SPACE ITALY, THALES BELGIUM, THALES DEUTSCHLAND, THALES CANADA, THALES SERVICES, SYSGO, GERAC, THALES ESPANA, THALES ALENIA SPACE ESPANA, THALES DIGITAL FACTORY, THALES SESO, THALES NORWAY, THALES RESEARCH & TECHNOLOGY Ltd, THALES NEDERLAND, THALES PORTUGAL, THALES ELECTRONICS Limited, THALES ALENIA SPACE UK, THALES OPTRONICS, THALES UK, THALES ASIA PTE, THALES TRANSPORT & SECURITY Ltd, THALES TRANSPORTATION SYSTEMS B.V, THALES GROUND TRANSPORTATION SYSTEMS UK LIMITED, THALES TRANSPORT & SECURITY INC. TAU may assign its Results Information Catalyst SL: Information Catalyst SL (ICE Spain) Attachment 5: Model Non-Disclosure Agreement for Industrial Advisory Board‌ Barcelona Supercomputing Center-Centro Nacional de Supercomputación (‘BSC’) and the organisations shown in the Attachment to Ramot at Tel Aviv University Ltd., this Agreement (the commercial arm of TAU, and/or to the researchers of TAU “Consortium”) are participating in the project entitled ELASTIC (the “Project”), which is being funded by the European Union’s. The Consortium welcomes you as a member of the Industrial Advisory Board(“IAB”). Participation as a member of the IAC will involve you receiving, and/or participating in Project discussions/presentations concerning information produced and/or acquired by the Consortium members either as part of the Project (“Foreground”) or before/outside the Project (“Background”). As the Consortium members have pre-existing obligations with respect to the confidentiality of such Foreground and Background, you will be required to keep confidential, as indicated below, any Foreground or Background that may be disclosed to you as a member of the IAB. In this agreement, any information disclosed to you relating to Foreground and/or Background shall be collectively referred to as “Confidential Information” and the Consortium member owning or holding rights to such Confidential Information, who shall be entitled to enforce the obligations contained herein, shall be referred to as the “Discloser”. To avoid doubt, the Consortium has approved the use of this agreement. By signing below, you agree to the following:

Grant Agreement. BGX hereby excludes from its obligation to grant Access Rights to Bacground including, but not limited to, the following: a) All Background developed by researchers working at BGX who are not participating in the THERACAT project and b) All Background developed by researchers working at BGX and participating in the THERACAT project, where this Background falls outside the scope of the Work Tasks allocated to BGX under the project, and c) All Background developed by researchers working at BGX which is subject to thir party rights or for which BGX needs to obtain permission grant Access Rights. This represents the status at the time of signature of this Consortium Agreement. Attachment 2: Accession document ACCESSION of a new Party to [Acronym of the Project] Consortium Agreement, version […, YYYY-MM-DD] [OFFICIAL NAME OF THE NEW PARTY AS IDENTIFIED IN THE Grant Agreement] hereby consents to become a Party to the Consortium Agreement identified above and accepts all the rights and obligations of a Party starting [date]. [OFFICIAL NAME OF THE COORDINATOR AS IDENTIFIED IN THE Grant Agreement] hereby certifies that the consortium has accepted in the meeting held on [date] the accession of [the name of the new Party] to the consortium starting [date]. This Accession document has been done in 2 originals to be duly signed by the undersigned authorised representatives. [Date and Place] [INSERT NAME OF THE NEW PARTY] Signature(s) Name(s) Title(s) [Date and Place] [INSERT NAME OF THE COORDINATOR] Signature(s) Name(s) Title(s) [Attachment 3: List of Third Parties for simplified transfer according to Section 8.3.2. TAU may assign its Results 8.2.2.] [Attachment 4: Identified Affiliated Entities according to Ramot at Tel Aviv University Ltd., the commercial arm Section 9.5] [Option Attachment 5: Template for Career Development Plan] Career Development Plan-Year 1 (Draft) Name of TAU, and/or to the researchers ESR: Department: Name of TAU participating in the ProjectSupervisor: Date: BRIEF OVERVIEW OF RESEARCH PROJECT AND MAJOR ACCOMPLISHMENTS EXPECTED (half page should be sufficient): LONG-TERM CAREER OBJECTIVES (over 5 years):

Grant Agreement. BGX hereby excludes from its obligation to grant Access Rights to Bacground including, but not limited to, the following: a) All Background developed by researchers working at BGX who are not participating in the THERACAT project and b) All Background developed by researchers working at BGX and participating in the THERACAT project, where this Background falls outside the scope of the Work Tasks allocated to BGX under the project, and c) All Background developed by researchers working at BGX which is subject to thir party rights or for which BGX needs to obtain permission grant Access Rights. This represents the status at the time of signature of this Consortium Agreement. Attachment 2: 2 Accession document ACCESSION of a new Party to [Acronym of the Project] NATURE-ETN Consortium Agreement, version […, YYYY-MM-DD] [OFFICIAL NAME OF THE NEW PARTY AS IDENTIFIED IN THE Grant Agreement] hereby consents to become a Party to the Consortium Agreement identified above and accepts all the rights and obligations of a Party starting [date]. [OFFICIAL NAME OF THE COORDINATOR AS IDENTIFIED IN THE Grant Agreement] hereby certifies that the consortium has accepted in the meeting held on [date] the accession of [the name of the new Party] to the consortium starting [date]. This Accession document has been done in 2 originals to be duly signed by the undersigned authorised representatives. [Date and Place] [INSERT NAME OF THE NEW PARTY] Signature(s) Name(s) Title(s) [Date and Place] [INSERT NAME OF THE COORDINATOR] Signature(s) Name(s) Title(s) Attachment 3: 3 List of Third Parties for simplified transfer according to Section 8.3.2. TAU may assign its Results The University of Oxford‘s wholly-owned technology transfer company: Attachment 4 Identified Affiliated Entities according to Ramot at Tel Aviv University Ltd., the commercial arm Sec. 9.5 Attachment 5 Template for Career Development Plan Career Development Plan-Year 1 (Draft) Name of TAU, and/or to the researchers ESR: Department: Name of TAU participating in the ProjectSupervisor: Date: BRIEF OVERVIEW OF RESEARCH PROJECT AND MAJOR ACCOMPLISHMENTS EXPECTED (half page should be sufficient): LONG-TERM CAREER OBJECTIVES (over 5 years):

Grant Agreement. BGX hereby excludes from its obligation to grant Access Rights to Bacground including, but not limited to, the following: a) All Background developed by researchers working at BGX who are not participating in the THERACAT project and b) All Background developed by researchers working at BGX and participating in the THERACAT project, where this Background falls outside the scope of the Work Tasks allocated to BGX under the project, and c) All Background developed by researchers working at BGX which is subject to thir party rights or for which BGX needs to obtain permission grant Access Rights. This represents the status at the time of signature of this Consortium Agreement. Etc. [Attachment 2: Accession document document] ACCESSION of a new Party to [Acronym of the Project] Consortium Agreement, version […, YYYY-MM-DD] [OFFICIAL NAME OF THE NEW PARTY AS IDENTIFIED IN THE Grant Agreement] hereby consents to become a Party to the Consortium Agreement identified above and accepts all the rights and obligations of a Party starting [date]. [OFFICIAL NAME OF THE COORDINATOR AS IDENTIFIED IN THE Grant Agreement] hereby certifies that the consortium has accepted in the meeting held on [date] the accession of [the name of the new Party] to the consortium starting [date]. This Accession document has been done in 2 originals to be duly signed by the undersigned authorised representatives. [Date and Place] [INSERT NAME OF THE NEW PARTY] Signature(s) Name(s) Title(s) [Date and Place] [INSERT NAME OF THE COORDINATOR] Signature(s) Name(s) Title(s) [Attachment 3: List of Third Parties for simplified transfer according to Section 8.3.2. TAU may assign its Results 8.2.2.] [Option: Attachment 4: Identified Affiliated Entities according to Ramot at Tel Aviv University Ltd.Section 9.5] [Option: Attachment 5: Template for Career Development Plan (EU-Template: xxxx://xx.xxxxxx.xx/research/mariecurieactions/funded-projects/how-to-manage/funded-projects/how-to-manage/itn/career_development_plan.doc)] Career Development Plan-Year 1 (Draft) Name of fellow: Department: Name of Supervisor: Date: Brief overview of research project and major accomplishments expected (half page should be sufficient): Long-term career objectives (over 5 years): Goals: What further research activity or other training is needed to attain these goals? Short-term objectives (1-2 years): Research results Anticipated publications: Anticipated conference, the commercial arm workshop attendance, courses, and /or seminar presentations: Research Skills and techniques: Training in specific new areas, or technical expertise etc: Research management: Fellowship or other funding applications planned (indicate name of TAUaward if known; include fellowships with entire funding periods, and/or to the researchers grants written/applied for/received, professional society presentation awards or travel awards, etc.) Communication skills: Other professional training (course work, teaching activity): Anticipated networking opportunities Other activities (community, etc) with professional relevance: Date & Signature of TAU participating in the Projectfellow: Date & Signature of supervisor Career Development Plan-Final year

Grant Agreement. BGX hereby excludes from its obligation to grant Access Rights to Bacground including, but not limited to, the following: a) All Background developed by researchers working at BGX who are not participating in the THERACAT project and b) All Background developed by researchers working at BGX and participating in the THERACAT project, where this Background falls outside the scope of the Work Tasks allocated to BGX under the project, and c) All Background developed by researchers working at BGX which is subject to thir party rights or for which BGX needs to obtain permission grant Access Rights. This represents the status at the time of signature of this Consortium Agreement. Attachment 2: Accession document ACCESSION of a new Party to [Acronym of the Project] Consortium Agreement, version […, YYYY-MM-DD] [OFFICIAL NAME OF THE NEW PARTY AS IDENTIFIED IN THE Grant Agreement] hereby consents to become a Party to the Consortium Agreement identified above and accepts all the rights and obligations of a Party starting [date]. [OFFICIAL NAME OF THE COORDINATOR AS IDENTIFIED IN THE Grant Agreement] hereby certifies that the consortium has accepted in the meeting held on [date] the accession of [the name of the new Party] to the consortium starting [date]. This Accession document has been done in 2 originals to be duly signed by the undersigned authorised representatives. [Date and Place] [INSERT NAME OF THE NEW PARTY] Signature(s) Name(s) Title(s) [Date and Place] [INSERT NAME OF THE COORDINATOR] Signature(s) Name(s) Title(s) Attachment 3: List of Third Parties for simplified transfer according to Section 8.3.2. TAU may assign its Results to Ramot at Tel Aviv University Ltd., the commercial arm of TAU, and/or to the researchers of TAU participating in the ProjectSection8.3.2 RUN-EU MODEL COLLABORATIVE RESEARCH AGREEMENT (PARTLY INDUSTRY FUNDED) Dated 20[●]

Grant Agreement. BGX hereby excludes from its obligation to grant Access Rights to Bacground including, but not limited to, the following: a) All Background developed by researchers working at BGX who are not participating in the THERACAT project and b) All Background developed by researchers working at BGX and participating in the THERACAT project, where this Background falls outside the scope of the Work Tasks allocated to BGX under the project, and c) All Background developed by researchers working at BGX which is subject to thir party rights or for which BGX needs to obtain permission grant Access Rights. This represents the status at the time of signature of this Consortium Agreement. IMMERSE Consortium Agreement, Signatory version. Attachment 2: Accession document ACCESSION of a new Party to [Acronym of the Project] Consortium Agreement, version […, YYYY-MM-DD] [OFFICIAL NAME OF THE NEW PARTY AS IDENTIFIED IN THE Grant Agreement] hereby consents to become a Party to the Consortium Agreement identified above and accepts all the rights and obligations of a Party starting [date]. [OFFICIAL NAME OF THE COORDINATOR AS IDENTIFIED IN THE Grant Agreement] hereby certifies that the consortium has accepted in the meeting held on [date] the accession of [the name of the new Party] to the consortium starting [date]. This Accession document has been done in 2 originals to be duly signed by the undersigned authorised representatives. [Date and Place] [INSERT NAME OF THE NEW PARTY] Signature(s) Name(s) Title(s) [Date and Place] [INSERT NAME OF THE COORDINATOR] Signature(s) Name(s) Title(s) IMMERSE Consortium Agreement, Signatory version. [Attachment 3: List of Third Parties for simplified transfer according to Section 8.3.2.] Party 6 (UHEI): none IMMERSE Consortium Agreement, Signatory version. TAU may assign its Results [Option: Attachment 4: Identified Affiliated Entities according to Ramot at Tel Aviv University Ltd.Section 9.5] Party 6 (UHEI): none IMMERSE Consortium Agreement, the commercial arm of TAU, and/or to the researchers of TAU participating in the ProjectSignatory version. Attachment 5: NDA template - Scientific and Ethical Advisory Board (SEAB) and Trial Steering Committee NON-DISCLOSURE AGREEMENT The ‘Agreement’